Reproductive hormones: Ageing and the perimenopause

Acta Obstetricia et Gynecologica Scandinavica

Volumn 81, Issue 7, 2002, Pages 612-616

  Robertson, David M ^a   Burger, Henry G ^a  

^a NONE   (Australia)

Author keywords

Estradiol; FSH; Inhibin B; LH; Menopause transition

Indexed keywords

ACTIVIN A; ESTRADIOL; FOLLISTATIN; FOLLITROPIN; INHIBIN B; LUTEINIZING HORMONE; MYELOPID;

AGE; AGING; CONFERENCE PAPER; FEMALE; FOLLICULAR PHASE; HUMAN; HYPOPHYSIS; LUTEAL PHASE; MENSTRUAL CYCLE; OVARY; OVARY FOLLICLE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGING; CLIMACTERIC; FEMALE; FOLLICLE STIMULATING HORMONE; GONADAL STEROID HORMONES; HUMANS; LUTEINIZING HORMONE; PITUITARY GLAND;

EID: 0036315269     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2002.810706.x     Document Type: Article

References (39)

1. Inhibin
2. The endocrinology of the menopause
3. Inhibin and related peptides in the regulation of reproduction
4. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cells fates in early Xenopus embryo
5. Inhibin B in men with normal and disturbed spermatogenesis
6. Inhibin B. likely candidate for the physiologically important form of inhibin in men
7. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction
8. Inhibin B levels in azoospermic subjects with cytologically characterized testicular pathology
9. Different roles of prepubertal and postpubertal germ cells and Sertoli cells in the regulation of serum inhibin B levels
10. Effects of chemotherapy-induced testicular damage on inhibin, gonadotropin, and testerone secretion: A prospective longitudinal study
11. Measurement of dimeric inhibin B throughout the human menstrual cycle
12. Two-site immunoassays for inhibin and its subunits. Further applications of the synthetic peptide approach
13. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle
14. Both Inhibin A and B respond to exogenous follicle stimulating hormone in the follicular phase of the human menstrual cycle
15. Inhibin A and inhibin B responses to gonadotropin withdrawal depends on stage of follicle development
16. The detection of diminished ovarian reserve in infertile women
17. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome
18. Relationship between serum inhibin A and B and ovarian follicle development following a daily fixed dose administration of recombinant FSH
19. Inhibin concentrations in women taking the oral contraceptive: Further evidence for FSH regulation of inhibin B secretion
20. Endocrine changes of the perimenopause
21. Reproductive aging: Accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women
22. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: A study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles
23. Serum Inhibins A and B fall differentially as FSH rises in perimenopausal women
24. Female reproductive aging is marked by decreased secretion of dimeric inhibin
25. Follicular depletion during the menopausal transition: Evidence for accelerated loss and ultimate exhaustion
26. Age-related changes of the population of human ovarian follicles: Increase in the disappearance rate of non-growing and early-growing follicles in aging women
27. Is follicular atresia biphasic?
28. Dimeric inhibin: A direct marker of ovarian aging
29. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy
30. Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women
31. The endocrinology of the menopause transition: A cross-sectional study of a population-based sample
32. Circulating immunoreactive inhibin levels during the normal human menstrual cycle
33. Combined inhibin and CA125 assays in the detection of ovarian cancer
34. Quantitation of inhibin Pro-αC-containing forms in human serum by a new ultrasensitive two-site enzyme-linked immunosorbent assay
35. Development and application of a two-site immunoassay for the determination of 'total' activin concentrations in serum and follicular fluid
36. A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state
37. Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin
38. Serum immunoreactive activin A levels in normal subjects and patients with various diseases
39. Serum activin A and follistatin concentrations during human pregnancy: A cross-sectional and longitudinal study